comparemela.com

Latest Breaking News On - Brexucabtagene autoleucel tecartus - Page 1 : comparemela.com

CAR-T Cell Therapy Market Size to Surpass USD 14 42 Billion by 2030, exhibiting a CAGR of 18 5%

As per the report by Fortune Business Insights, the global CAR-T Cell Therapy Market size is projected to reach USD 14.42 billion in 2030, at a CAGR of 18.5% during the forecast period, 2023-2030 CAR-T Cell Therapy Market Forecast 2023-2030 Pune, India, Sept. 25, 2023 (GLOBE NEWSWIRE) Global CAR-T Cell Therapy Market Size was valued at USD 2.72 billion in 2022 and is projected to grow from USD 14.42 billion by 2030 exhibiting a CAGR of 18.5% during forecast period. The growing prevalence of c

Global CAR T Cell Therapy Clinical Pipeline Report 2022-2028: Pharma Giants are Increasingly Partnering/Collaborating with Technology Companies to Integrate Advanced Technologies

Worldwide CAR T-Cell Therapy Industry to 2030 - Players Include Legend Biotech, Novartis & Pfizer Among Others

Share this article Share this article ResearchAndMarkets.com s offering. The scientific community has been pursuing research for the development of CAR T-cell therapy for over a century. Immunotherapy has emerged as an innovative treatment option over decades, as it harnesses the patient s immune system to attack cancer. The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030. The market is driven by certain factors, which include increasing global geriatric population, increasing number of lymphoma and leukemia cases, rising number of relapsed or refractory cancer cases showing response failure to alternative treatments such as chemotherapy and radiation therapy, focus on research and development of novel immunotherapies, and strong product pipeline of global CAR T-cell therapy.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.